
India cuts prices of 137 cancer drugs
India has reduced the prices of 137 cancer drugs by up to seventy percent and limited trade margins to thirty percent. The new price controls take effect on November nine.

India will cut the prices of 137 cancer drugs by as much as 70% as the government expands price controls to improve treatment affordability. The latest policy caps trade margins at 30% of the maximum retail price across key oncology medications. The price reductions take effect on November 9, following a Saturday announcement from the Ministry of Chemicals and Fertilizers.










